PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

Market Cap	6.73B
Revenue (ttm)	1.69B
Net Income (ttm)	219.54M
Shares Out	198.89M
EPS (ttm)	1.10
PE Ratio	30.75
Forward PE	24.33
Dividend	0.31 (0.90%)
Ex-Dividend Date	May 30, 2025

Volume	9,486,401
Average Volume	6,549,488
Open	32.91
Previous Close	34.34
Day's Range	32.91 - 34.46
52-Week Range	24.38 - 45.80
Beta	0.75
RSI	56.14
Earnings Date	Aug 15, 2025

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and Full Time Equivalent (FTE). The company also provides small molecule drug substance CDMO se...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 2,455
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300725

Financial Performance

In 2024, SHE:300725's revenue was 1.69 billion, a decrease of -2.12% compared to the previous year's 1.73 billion. Earnings were 219.54 million, an increase of 11.24%.